Kelley Boucher - 28 May 2025 Form 3 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Signature
/s/ David Watson, attorney-in-fact for Kelley Boucher
Issuer symbol
APLS
Transactions as of
28 May 2025
Net transactions value
$0
Form type
3
Filing time
29 May 2025, 11:44:09 UTC
Next filing
11 Jun 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Boucher Kelley Chief People Officer C/O APELLIS PHARMACEUTICALS, INC., 100 FIFTH AVENUE, 3RD FLOOR, WALTHAM /s/ David Watson, attorney-in-fact for Kelley Boucher 29 May 2025 0002070437

No securities are beneficially owned.